CAMERON W BRENNAN, MD
Medical Practice at York Ave, New York, NY

License number
New York 210534-1
Category
Medical Practice
Type
Neurological Surgery
Address
Address
1275 York Ave, New York, NY 10021
Phone
(212) 639-2000

Personal information

See more information about CAMERON W BRENNAN at radaris.com
Name
Address
Phone
Cameron Brennan
436 E 69Th St APT 3D, New York, NY 10021
(212) 861-8405
Cameron Brennan
436 69Th St, New York, NY 10021
(212) 861-8405

Professional information

Cameron Brennan Photo 1

Dr. Cameron Brennan, New York NY - MD (Doctor of Medicine)

Specialties:
Neurosurgery, Cancer Research
Address:
MSKCC SURGERY GROUP
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
MSKCC
1275 York Ave, New York 10065
(866) 425-8999 (Phone)
Procedures:
Brain Tumor Surgery, Radio Surgery, Tumor Ablation, Tumor Resection
Conditions:
Acoustic Neuroma, Brain and Nervous System - Brain Tumors, Brain Cancer, Brain Metastasis, Glioblastoma, Meningiomas
Certifications:
Neurosurgery
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MSKCC SURGERY GROUP
1275 York Ave, New York 10065
MSKCC
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Education:
Medical School
Joan Sanford I Weill Medical College Of Cornell University
Graduated: 1994
The New York Hosp-Cornell Med Ctr
Graduated: 2000
Dana-Farber/Harvard
Graduated: 2004
Memorial Sloan Kettering Cancer Center
Graduated: 2001
Brown University
Graduated: 1988


Cameron W Brennan Photo 2

Cameron W Brennan, New York NY

Specialties:
Neurological Surgery
Work:
Memorial Sloan-Kettering
1275 York Ave, New York, NY 10065
Education:
Cornell University (1994) *, NewYork-Presbyterian / Weill Cornell (2000) *Neurological Surgery, Memorial Sloan Kettering Cancer Center (2001) *Neurological Surgery, Dana Farber Cancer Institute, Harvard Medical School (2004) *


Cameron Walter Brennan Photo 3

Cameron Walter Brennan, New York NY

Specialties:
Neurosurgeon
Address:
436 E 69Th St, New York, NY 10021
1275 York Ave, New York, NY 10065


Cameron Brennan Photo 4

Compostions, Kits, And Methods For Identification, Assessment, Prevention, And Therapy Of Cancer

US Patent:
2008007, Mar 27, 2008
Filed:
Feb 13, 2007
Appl. No.:
11/706155
Inventors:
Ronald DePinho - Brookline MA, US
Kenneth Anderson - Wellesley MA, US
Ruben Carresco - Brookline MA, US
Giovanni Tonon - Brookline MA, US
Cameron Brennan - New York NY, US
John Shaughnessy - Roland AR, US
Lynda Chin - Brookline MA, US
International Classification:
A61K 31/70, A01K 67/00, A61K 38/00, A61K 39/395, A61P 43/00, C07H 21/00, C07K 14/00, C12Q 1/68, C40B 30/04, G01N 33/574
US Classification:
424138100, 424178100, 435006000, 435007230, 506009000, 514002000, 514044000, 530350000, 536023100, 800003000
Abstract:
The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.


Cameron Brennan Photo 5

Compositions, Kits, And Methods For Identification, Assessment, Prevention And Therapy Of Cancer

US Patent:
2009029, Dec 3, 2009
Filed:
May 27, 2005
Appl. No.:
11/597825
Inventors:
Lynda Chin - Brookline MA, US
Cameron W. Brennan - New York NY, US
Ronald A. DePinho - Brookline MA, US
Andrew J. Aguirre - Boston MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 39/395, C12Q 1/68, C40B 30/00, A01K 67/00, A61K 31/7052, A61K 38/02, A61K 38/16, C07K 14/00, C07H 21/00, C07K 16/00, A61P 35/00
US Classification:
4241721, 435 6, 506 7, 800 10, 4241831, 4241781, 514 44 A, 514 2, 514 12, 530350, 536 231, 5303891
Abstract:
The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.